DaVita Venture Group

Rounds

• R R1 TherapeuticsDevelops AP306 for hyperphosphatemia in dialysis kidney disease patients $77.5MSeries A · 17 Mar
• G Greater Good HealthNurse practitioner-led value-based primary care for Medicare patients $20.5MSeries B · 5 Mar

No round matches these filters.

Often invests with

• Abingworth1
• Allumia Ventures1
• Curie.Bio1
• F-Prime1
• Flare Capital Partners1
• Granite Financial Holdings1
• LRVHealth1
• Optum Ventures1